Fifteen hours a week. $70,000+ captured. Six months.
Greg* runs a single-location independent pharmacy on PioneerRx. He didn't hire anyone new. He didn't change his workflow. He pointed his part-time tech Jessica* at the opportunity list TheRxOS surfaces every morning and let her work. Here's exactly what happened.
First client. Longest run. Clearest proof.
Greg's pharmacy committed to TheRxOS when beta meant exactly that: real data, real results, real friction. They've seen the bugs. They've worked around the quirks. They've pushed through workflows that weren't yet seamless.
And through all of it, one thing didn't waver — the data surfaced real money, and they captured it. What the Greg's Pharmacy team understood early is that the imperfections of a beta system don't change the math of a legitimate clinical opportunity.
If the NDC switch is real, it's real. If the therapeutic interchange is valid, the prescriber approval generates margin. The system found both — and it keeps finding them every day.
Six payments in. $3,594 paid to the subscription. $70,000+ captured. The math is not theoretical.
The operational setup was intentionally lean. One pharmacist intern — Jessica* — working part-time, roughly 15 hours per week, handled all opportunity review and prescriber outreach. No additional FTE. No operational overhaul. No new department.
This is the model: a focused staff member works through the opportunity queue the system surfaces. She validates, she submits, she reconciles. The platform does the daily scanning and detection. The human closes the loop.
And this is at one pharmacy, running a tool that was still half-built when they started. That's the part that matters.
Six payments. The money keeps coming.
A clear picture of how the model compounds when you point a focused tech at a prioritized list every morning.
Data in. First opportunities flagged.
PMS export connected within the first week. The daily claims scan ran and surfaced the first batch of therapeutic interchange candidates and NDC optimization targets. Jessica started working through the dashboard — manually, methodically, without a perfectly polished UX. The data was clear enough to act on. That was enough.
Momentum builds. Cadence forms.
By month two, Jessica had developed a working cadence. Roughly 15 hours per week — reviewing flagged opportunities, submitting eRx change requests, reconciling approvals back to dispensed claims. The system had its beta quirks. Greg's team worked around them. Prescribers responded. Margin showed up in the data.
$45,000 captured in under 90 days.
By month three, the system had matured — new triggers, better coverage data, and a tech who knew the workflow cold. The captured revenue had already justified bringing on additional part-time hours. The program paid for more staff. Three payments in: $1,797 paid, $45,000+ captured — the original 90-day proof point.
Same tech. Same hours. $45K becomes $70,000+.
Nothing changed operationally in months four through six. Jessica kept working the same daily queue on the same part-time schedule — and the number kept climbing. Every converted opportunity continues to pay on refill, so capture compounds on work already done. This is the part a 90-day snapshot can't show: the money keeps coming in after the push.
One part-time tech. Fifteen hours. No chaos.
TheRxOS doesn't require a new FTE or a clinical team. Greg's Pharmacy proved it runs as a part-time layer on top of normal operations — and the throughput ratio versus fully manual work isn't close.
One pharmacist intern, working part-time. No new full-time hire. 100+ opportunity submissions per week — roughly 7× the throughput of fully manual workflow.
Opportunity review · daily
Jessica works through the flagged queue each morning — validating therapeutic interchange candidates and NDC switches before any outreach is submitted. Highest dollar value first.
eRx change request submission
Instead of fax, Greg's Pharmacy leveraged eRx change requests for prescriber outreach — a workflow distinction that may prove significant as data accumulates across clients.
Approval tracking & reconciliation
Jessica monitors prescriber responses, flags approved changes, and reconciles them against dispensed claims to confirm capture — the only way you know what actually hit.
The platform does the heavy lifting
Daily claims scan, opportunity detection, prescriber deduplication, and evening reconciliation all run automatically. No manual data entry. No spreadsheets.
eRx change requests vs. fax: an emerging signal, not yet a conclusion.
Greg's Pharmacy used eRx change requests rather than traditional fax for prescriber outreach — a meaningful workflow distinction. Whether this translates to higher approval rates or faster turnaround is a hypothesis, not yet a finding. It requires comparison data from additional pharmacies before we can draw any conclusion.
What is clear: the performance speaks for itself regardless of attribution. As more clients come online, this variable will either prove significant or it won't. The data will tell us. We're publishing the observation now so we're on record.
$3,594 paid. $70,000+ back.
Six payments. One part-time tech. Roughly nineteen times the subscription cost returned in six months — and the number is still moving.
All-in view: Intern labor at ~15 hrs/week × ~26 weeks × $20/hr ≈ $7,800. Total six-month spend including labor: ~$11,400. Net gain: ~$58,600 in six months. Even the worst-case accounting returns roughly 6× on total spend. And every converted opportunity continues to pay on refill — months four through six are largely that compounding tail doing its work.
"The system didn't need to be perfect. The opportunities needed to be real. They were. That's the entire job."
Greg* · Owner · Single-location independent · PioneerRx · Beta cohort*Names changed at the pharmacy's request. Independent pharmacy owners who publicly optimize around PBM economics face retaliation through audits, contract non-renewals, and reimbursement adjustments. We protect every client who asks. Verifiable results and real names available under NDA on a demo call.
The pattern repeats.
Maria's Pharmacy* went live with TheRxOS in January 2026. Different pharmacy, same playbook: the platform surfaces the daily opportunity queue, a staff member works it, captured revenue gets reconciled against dispensed claims.
Five months in, they've captured $8,000+ — and the number climbs the same way Greg's did: steadily, on ordinary weeks, without the owner becoming an analyst.
One pharmacy is a story. Two is a pattern forming. The next data point could be yours.
Captured since January
Reconciled against dispensed claims, still climbing.
Program entry
Live within the first week of onboarding.
Second verified case file
Same daily queue. Same workflow. No custom build.
Your pharmacy has the same data. Find yours.
Upload your claims. See your opportunities. No credit card. No pressure. If the number doesn't move you, you walk away.